Skip to content
Menu

Johnson & Johnson JNJ

Full chart Compare
Set alert

Price alert · JNJ

All alert types
267.14 USD -5.56 (-2.04%)

Regular-session close

266.47 -0.67 -0.25%

After hours · Nov 19, 6:49 PM ET

264.68 Day range 270.60
199.91 52-week range 290.25
YTD
+29.08%
1 year
+31.91%

Fundamental scorecard

15 of 25 checks passed on JNJ’s reported financials

ValueGrowthProfitabilityHealthDividend

15of 25 checks passed

  • Value 0 of 5
  • Growth 3 of 5
  • Profitability 4 of 5
  • Financial health 4 of 5
  • Dividend 4 of 5

Statements to Sep 27, 2026.

Value 0 of 5

  • Failed:P/E below its own 5-year median P/E 40.0 against a 5-year median of 21.6.
  • Failed:P/E under 20 P/E 40.0: an earnings yield of 2.5%.
  • Failed:Price to sales below its own 5-year median Price to sales 6.5 against a 5-year median of 5.3.
  • Failed:Price to book below its own 5-year median Price to book 7.9 against a 5-year median of 6.0.
  • Failed:Free cash flow yield above 4% Free cash flow of 20.6B is 3.2% of the market value.

Growth 3 of 5

  • Passed:Revenue grew over the last year Revenue of 99.3B is +7.8% on the 12 months before.
  • Failed:Revenue grew more than 5% a year over five years +2.7% a year from FY 2020 to FY 2025.
  • Failed:Earnings per share grew over the last year EPS 6.58 against 10.35 in the 12 months before.
  • Passed:Earnings per share grew more than 5% a year over five years +14.9% a year from FY 2020 to FY 2025.
  • Passed:Analysts expect higher earnings per share over the next year The average forward estimate is +76.2% on the last 12 months.

Profitability 4 of 5

  • Passed:Profitable over the last year Net income of 16.1B over the last 12 months.
  • Passed:Profitable in each of the last five fiscal years A profit in 5 of the last 5 fiscal years.
  • Passed:Return on equity above 15% Return on equity of 20.0%.
  • Failed:Net margin above its 5-year average Net margin of 16.2% against a 5-year average of 26.9%.
  • Passed:Free cash flow is at least 80% of net income Free cash flow of 20.6B is 127.9% of net income.

Financial health 4 of 5

  • Passed:Short-term assets cover short-term liabilities Short-term assets of 56.4B against short-term liabilities of 55.5B.
  • Failed:Short-term assets cover long-term liabilities Short-term assets of 56.4B against long-term liabilities of 60.4B.
  • Passed:Net debt under 40% of equity Net debt of 27.4B is 33.6% of equity.
  • Passed:Operating cash flow covers at least 20% of debt Operating cash flow of 26.2B is 58.6% of debt.
  • Passed:Operating profit covers interest at least 3 times Operating profit is 19.0 times the interest expense.

Dividend 4 of 5

  • Passed:Pays a dividend 12.7B paid over the last 12 months.
  • Passed:Yield above 1.5% A yield of 2.0% at the current market value.
  • Failed:Pays out under 75% of profit 79.0% of net income is paid out.
  • Passed:Covered by free cash flow 61.8% of free cash flow is paid out.
  • Passed:Not cut in the last five fiscal years The total paid did not fall in any of the last five fiscal years.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Financial position

What JNJ owns and owes, as of Sep 27, 2026

Short term and long term

Balance sheet · 197B of assets

Debt, equity and cash by year

Now: 27.4B of debt after cash

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

5.41 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B+3 / 5 overall

  • DCF 4
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E 18.8×
P/S 5.4×
P/B 6.2×
P/FCF 25.6×
EV/EBITDA 13.0×
EV/Sales 5.7×
FCF Yield 3.9%

Profitability

Gross Margin 67.9%
Operating Margin 27.2%
Net Margin 28.5%
ROE 32.9%
ROIC 13.7%
ROA 13.5%

Growth (YoY)

Revenue 6.0%
Operating Income 15.6%
EPS (diluted) 90.5%
Free Cash Flow -0.7%

Financial Health

Current Ratio 1.0×
Quick Ratio 0.8×
Debt / Equity 0.6×
Net Debt / EBITDA 0.7×
Interest Coverage 26.4×

Dividends

Dividend Yield 2.5%
Payout Ratio 46.2%

Annual · latest fiscal year ends 2025-12-28